EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

William J Phillips, Michelle Pradier, Rachel Goodwin, Michael Vickers, Tim Asmis

Current Oncology · 2024

DOI: 10.3390/curroncol31020071 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Current Oncology, 2024. Verfasst von William J Phillips und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, The University of Ottawa, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: COVID-19, Intestinal Neoplasms, Neuroendocrine Tumors, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The COVID-19 pandemic resulted in an unprecedent shift towards virtual cancer care, including the care of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aim of this study was to evaluate the use of virtual care for GEP-NETs during the COVID-19 pandemic at a high-volume academic cancer center.

Methods

This retrospective, observational study performed at the Ottawa Hospital Cancer Center in Canada evaluated adult patients with GEP-NETs seen in consultation by medical oncology between 1 June 2019 and 31 December 2022. Demographic, clinicopathologic, cancer treatment and visit data were collected. Univariable and multivariable analyses assessed the relationship between patient characteristics and virtual care use.

Results

A total of 103 patients with well-differentiated GEP-NETS were included. Overall, 18/103 (17.5%) consults and 594/781 (76.1%) follow-ups were performed virtually. All consultation visits returned to in-person assessment by 2022, while 67.0% and 41.4% follow-ups remained virtual in 2022 and 2023, respectively. The year of follow-up, sex, employment and Charlston comorbidity index were associated with virtual follow-up use in the multivariable analysis.

Discussion

Virtual care remained a predominant method of GEP-NET patient assessment in the peri-pandemic period. These results highlight an opportunity to improve access to subspecialty neuroendocrine cancer care through the continued use of virtual care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Intestinal NeoplasmsNeuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsAdultHumansPandemicsRetrospective StudiesOntario

Stichwörter der Autor:innen

COVID-19carcinoidneuroendocrine tumoroncologyvirtual care

Autor:innen und Institutionen

  • Division of Medical Oncology, The University of Ottawa, Ottawa, ON K1H 8L6, Canada.
  • Faculty of Medicine, The University of Ottawa, Ottawa, ON K1H 8L6, Canada.
  • Division of Medical Oncology, The University of Ottawa, The Ottawa Hospital Cancer Centre, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.

Zitieren

APA

Phillips, W. J., Pradier, M., Goodwin, R., Vickers, M., & Asmis, T. (2024). Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Current Oncology. https://doi.org/10.3390/curroncol31020071

Vancouver

Phillips WJ, Pradier M, Goodwin R, Vickers M, Asmis T. Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Current Oncology. 2024. doi:10.3390/curroncol31020071

BibTeX
@article{Phillips2024,
  author = {Phillips, William J and Pradier, Michelle and Goodwin, Rachel and Vickers, Michael and Asmis, Tim},
  title = {Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31020071}
}
Kostenlos starten →